Literature DB >> 6087185

In vitro biochemical characterization and autoradiographic distribution of 3H-thyrotropin-releasing hormone binding sites in rat brain sections.

W H Rostène, J L Morgat, M Dussaillant, T C Rainbow, A Sarrieau, M Vial, G Rosselin.   

Abstract

In the present study, we describe the biochemical characteristics and the autoradiographic distribution of thyrotropin-releasing hormone (TRH) receptors in the rat central nervous system (CNS) after in vitro incubation of brain slices with 3H-TRH. Scatchard analysis showed that, in the range of concentrations tested (0.7-35 nM), 3H-TRH bound to a single-class of receptors with a dissociation constant of 6 nM and a number of binding sites of 20 fmol/mg protein. Increasing concentrations of unlabeled TRH produced a dose-dependent inhibition of 3H-TRH binding. The only analogue as potent as TRH to displace 3H-TRH binding was 3-Me-TRH, whereas 1-Me-TRH or TRH-free acid as well as pGlu-His, pGlu-Pro-NH2 or His-Pro-diketopiperazine were ineffective. Neither Luteinizing hormone-releasing hormone (LHRH), neurotensin, somatostatin, D-Ala-Met-enkephalin nor VIP showed any significant affinity for TRH binding sites. Autoradiograms obtained by apposition of LKB 3H-Ultrofilm showed that the highest concentrations of 3H-TRH binding sites were found in the ventral dentate gyrus of the hippocampal formation, the lateral amygdaloid nucleus, the nucleus accumbens, and the thalamic paraventricular nucleus. The biochemical characterization of 3H-TRH binding in brain sections is in good agreement with previous reports on membrane preparations and the autoradiographic localization of the binding sites provides anatomical support for the effects of TRH in the CNS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087185     DOI: 10.1159/000123960

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  6 in total

1.  Radioimagers as an alternative to film autoradiography for in situ quantitative analysis of 125I-ligand receptor binding and pharmacological studies.

Authors:  M Crumeyrolle-Arias; M Jafarian-Tehrani; A Cardona; L Edelman; P Roux; P Lanièce; Y Charon; F Haour
Journal:  Histochem J       Date:  1996-11

2.  Neuropeptides TRH and cyclo(His-Pro) share neuromodulatory, but not stimulatory, action on hypothalamic neurons in vitro: implication for the regulation of feeding.

Authors:  L M Kow; D W Pfaff
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

3.  Effect of chronic intra-accumbens administration of the TRH analogue CG3509 on histamine-induced behaviour in the rat.

Authors:  L J Bristow; G W Bennett
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

4.  Identification of the thyrotropin-releasing-hormone-degrading ectoenzyme as a metallopeptidase.

Authors:  G Czekay; K Bauer
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

5.  Changes of phorbol ester binding sites in rat brain following intracerebroventricular administration of thyrotropin-releasing hormone (TRH): an in vitro macroautoradiographic investigation.

Authors:  K Mizukawa; N Otsuka; N Ogawa; K Haba; A Mori
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

Review 6.  Thyrotropin-releasing hormone (TRH) in the cerebellum.

Authors:  Nobuyuki Shibusawa; Koshi Hashimoto; Masanobu Yamada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.